In-depth with Modern Meadow: the start-up bioengineering leather in a lab

Modern Meadow

Modern Meadow

It’s one thing to say you’re working on the future of textiles, but it’s another altogether to be doing so with living cells.

That’s the premise of Modern Meadow, a biofabrication company growing animal-free leather in a lab. Until now it’s operated in the research and development space, but a recent $40 million Series B round of financing led by Horizons Ventures and Iconiq Capital, will enable it to now transition into manufacturing.

In a few years, that means we’ll be able to buy products that do indeed look and feel like leather, but are engineered from collagen protein instead. The result has the potential to have a significant impact on leather as a $100 billion raw material market; helping to satisfy increasing demand as well reduce the harm it currently has on both animals and the environment.

Head over to Forbes to read the full interview with Modern Meadow’s chief creative officer, Suzanne Lee, who talks about exactly what enhanced properties these leathers can have, the role sustainability plays in the need for this work and what the limitations are to get it to market.